id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2019-0007-0002,DEA,DEA-2019-0007,6b-Naltrexol DEcontrol -Incoming HHS Letter + Enclosures,Supporting & Related Material,,2019-08-23T04:00:00Z,2019,8,,,2019-08-23T19:38:03Z,,0,0,0900006483eb0dba
DEA-2019-0007-0003,DEA,DEA-2019-0007,6B-Naltrexol_ 8F Analysis_08_2019 DOE,Supporting & Related Material,,2019-08-23T04:00:00Z,2019,8,,,2019-08-23T19:38:18Z,,0,0,0900006483eb0dbc
DEA-2019-0007-0001,DEA,DEA-2019-0007,Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control,Proposed Rule,,2019-08-21T04:00:00Z,2019,8,2019-08-21T04:00:00Z,2019-09-21T03:59:59Z,2021-03-14T09:28:20Z,2019-17630,0,0,0900006483e7ef77